Cristiano, Antonio, et al. “The Venetoclax Azacitidine Combination Targets the Disease Clone in Acute Myeloid Leukemia, Being Effective and Safe in a Patient With COVID : VEN AZA Effectively Targets AML Clones”. Mediterranean Journal of Hematology and Infectious Diseases, vol. 14, no. 1, Apr. 2022, p. e2022041, doi:10.4084/MJHID.2022.041.